Name: Latest research reports of Abbott India Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Abbott India Ltd.
Rating: 3
Author: ICICI Securities Limited

Abbott India Ltd.

NSE: ABBOTINDIA | BSE: 500488 | ISIN: INE358A01014 | Industry: Pharmaceuticals
| Expensive Performer

29540.9000 -777.10 (-2.56%)

NSE Apr 02, 2025 15:31 PM

52W high on Mar 05, 2025

Volume: 8,629

Abbott India Ltd.

11 Aug 2022

29540.90

-2.56%

Margins contract; stock fairly priced

Hold: Abbott India Ltd.

Recommendation Target

ICICI Securities Limited

Abbott India’s (AIL) Q1FY23 performance was below our estimate on the profitability front.

Abbott India Ltd. is trading below its 30 day SMA of 30248.0